Nature Communications (Oct 2022)
A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing
Abstract
Achieving spatial control of gene expression is important. Here the authors report an optimised photoactivatable Cre recombinase system, doxycycline- and light-inducible Cre recombinase (DiLiCre), and generate a DiLiCre mouse line which they use for mutagenesis in vivo and positional cell-tracing.